Ovid Therapeutics Inc

NASDAQ:OVID  
2.69
0.00 (-0.19%)
Other Pre-Announcement

Ovid Therapeutics Reports Q3 2020 Financial Results

Published: 11/12/2020 21:49 GMT
Ovid Therapeutics Inc (OVID) - Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.28.
Q3 Earnings per Share Estimate $-0.36 -- Refinitiv Ibes Data (analyst estimates).
As of September 30, 2020, Cash and Cash Equivalents Totaled $86.9 Million.
Revenue Was $6.9 Million for Q3 Ended September 30, 2020, As Compared to Zero for Same Period in 2019.